AbbVie Inc (ABBV)
Fixed asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 56,334,000 | 54,318,000 | 58,054,000 | 56,197,000 | 45,804,000 |
| Property, plant and equipment | US$ in thousands | — | — | 4,935,000 | 5,110,000 | 5,248,000 |
| Fixed asset turnover | — | — | 11.76 | 11.00 | 8.73 |
December 31, 2024 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $56,334,000K ÷ $—K
= —
The fixed asset turnover ratio for AbbVie Inc has shown a consistent increasing trend from 8.73 in December 31, 2020, to 11.00 in December 31, 2021, and further to 11.76 in December 31, 2022. This indicates that the company is generating more revenue relative to its investment in fixed assets, which is a positive sign of operational efficiency. However, the data is not available for December 31, 2023, and December 31, 2024, which could be due to various reasons such as changes in reporting practices or incomplete data. Overall, the increasing trend in fixed asset turnover suggests that AbbVie Inc is effectively utilizing its fixed assets to generate sales.
Peer comparison
Dec 31, 2024